Bridgeway Capital Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-275,200
| Closed | -$1.42M | – | 1340 |
|
|
2019
Q4 | $1.42M | Sell |
275,200
-30,000
| -10% | -$154K | 0.02% | 651 |
|
|
2019
Q3 | $1.58M | Hold |
305,200
| – | – | 0.02% | 600 |
|
|
2019
Q2 | $1.85M | Hold |
305,200
| – | – | 0.02% | 557 |
|
|
2019
Q1 | $2.21M | Hold |
305,200
| – | – | 0.03% | 491 |
|
|
2018
Q4 | $2.26M | Sell |
305,200
-65,000
| -18% | -$481K | 0.03% | 454 |
|
|
2018
Q3 | $2M | Hold |
370,200
| – | – | 0.02% | 636 |
|
|
2018
Q2 | $1.31M | Buy |
370,200
+195,200
| +112% | +$693K | 0.01% | 770 |
|
|
2018
Q1 | $359K | Buy |
+175,000
| New | +$359K | ﹤0.01% | 1166 |
|
|
2015
Q1 | – | Sell |
-249,100
| Closed | -$1.95M | – | 1514 |
|
|
2014
Q4 | $1.95M | Hold |
249,100
| – | – | 0.04% | 524 |
|
|
2014
Q3 | $1.22M | Hold |
249,100
| – | – | 0.03% | 678 |
|
|
2014
Q2 | $1.54M | Sell |
249,100
-1,050
| -0.4% | -$6.49K | 0.04% | 601 |
|
|
2014
Q1 | $1.34M | Buy |
250,150
+1,050
| +0.4% | +$5.62K | 0.04% | 645 |
|
|
2013
Q4 | $1.3M | Sell |
249,100
-28,400
| -10% | -$149K | 0.04% | 646 |
|
|
2013
Q3 | $1.53M | Sell |
277,500
-280,000
| -50% | -$1.55M | 0.05% | 530 |
|
|
2013
Q2 | $1.41M | Buy |
+557,500
| New | +$1.41M | 0.06% | 487 |
|